News

Immix Biopharma, Inc, a biopharmaceutical company pioneering Tissue-Specific Therapeutics (TSTx)TM targeting oncology and immuno-dysregulated diseases, announced patient dosing in its ongoing Phase 1b/2a IMX-110 monotherapy clinical trial. This is the fifteenth patient dosed with IMX-110 to-date. IMX-110 clinical trial...

HitGen Inc announced that it has entered into a research agreement with Nitrase Therapeutics, Inc. , a biopharmaceutical company deploying its NITROME platform to build a pipeline of therapies targeting nitrases, which is a new class of enzymes discovered...

Kuehne+Nagel has entered into a long-term agreement for a new airside facility strategically located in the airport zone of OR Tambo International airport, Johannesburg, South Africa – the largest and busiest airport in Africa. As part of this agreement,...

Vertex Pharmaceuticals and Entrada Therapeutics, Inc. entered a global collaboration focused on discovering and developing intracellular Endosomal Escape Vehicle (EEV™) therapeutics for myotonic dystrophy type 1 (DM1). The collaboration includes Entrada’s program for DM1, ENTR-701, which is in late-stage...

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation announced the creation of a dedicated center to enhance Emmes' legacy and depth in cell and gene therapy research. The new...

Between 2022 and 2027, the market for medical device packaging is anticipated to expand by $15.66 billion at a CAGR of 10.16%. In the research published by Technavio in November, it was predicted that Europe would contribute 29% of the...

A mechanism that employs urea to begin the manufacturing of proteins in the massive amounts required by the biotech industry has been developed by researchers at the Universities of Birmingham and Aston. Typically, in this procedure, little DNA fragments are...